Showing results (41-50 of 106) with videos related to
Sort By:
Pageof 11
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 10, 2018
Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic StrategiesChrysoula Papageorgiou, Georges Jourdi, Eusebe Adjambri, et al.Annales De Biologie Clinique|December 5, 2012
[Post partum acquired hemophilia A with fatal outcome: a case report]Mourad Chaari, Riadh Bouhlel, Samy Kallel, et al.Thrombosis and Haemostasis|November 10, 2019
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter TrialJob Harenberg, Jan Beyer-Westendorf, Mark Crowther, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|October 1, 2021
Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs - A Systematic Review and Meta-analysisAndrea Martini, Job Harenberg, Rupert Bauersachs, et al.Journal of Perinatal Medicine|August 3, 2020
COVID-19, neutrophil extracellular traps and vascular complications in obstetric practiceAlexander Makatsariya, Ekaterina Slukhanchuk, Viktoriya Bitsadze, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 6, 2023
Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral AnticoagulantsLoula Papageorgiou, Svetlana Hetjens, Jawed Fareed, et al.International Angiology : a Journal of the International Union of Angiology|November 19, 2015
Rapid detection of D-Dimers with mLabs® whole blood method for venous thromboembolism exclusion. Comparison with Vidas® D-Dimers assayGrigoris T Gerotziafas, Patrick Ray, Vasiliki Gkalea, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 16, 2008
Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?Philippe Debourdeau, Ismail Elalamy, Axelle de Raignac, et al.Thrombosis Research|November 5, 2013
The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacementMichalis N Gionis, Christos V Ioannou, Asterios N Katsamouris, et al.Expert Review of Hematology|December 11, 2012
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosisEileen M Boyle, Guillemette Fouquet, Salomon Manier, et al.Pageof 11